Chronic renal failure. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: Dialysate is a pharmed pharmacy company that contains sodium, potassium, magnesium, calcium and bicarbonate ions at temperatures of 36 ° C. Intervention 2: Control
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients have been under hemodialysis for at least 6- 3 months prior to the study Patients have not received antiarrhythmic drugs (inotropic, digoxin, beta blockers, etc.). The patient's blood pressure should not exceed 150/100 mmHg
Exclusion criteria
Exclusion criteria: Patient death Unwillingness to continue participating in the study Intolerance to cold dialysis solution (if it is severe chills) In the event of an increase in blood pressure, the patient will have 30mmHg more than the baseline or greater than 170mmHg
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of arrhythmias during hemodialysis. Timepoint: Since the beginning of hemodialysis to an hour after dialysis. Method of measurement: Central Monitor,Holter monitoring.;Hemodynamic status (Blood pressure, heart rate, respiratory rate, temperature). Timepoint: Since the beginning of hemodialysis to an hour after dialysis. Method of measurement: Central Monitor. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stability of cardiovascular status during dialysis. Timepoint: Since the beginning of hemodialysis to an hour after dialysis. Method of measurement: central monitor? Holter monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactForozande Vatanparast
Rafsanjan University of Medical Sciences
Outcome results
None listed